Spinal muscular atrophy is a rare and fatal genetic disease  Most children live for less than 20 months  Recently, researchers have used a new gene therapy to develop a biotechnology drug SpinrA zA  , By injecting administration around the spinal cord of the patient, SpinrA zA  restored nearly half of the 73 tested patients to varying degrees of motor function
This gene therapy can also be used to treat other diseases.
 Based on this, the researchers concluded: This new gene therapy will bring breakthrough progress in the treatment of spinal muscular atrophy